Instratek Reports 10th Straight Year of Record Revenue Growth and Launch of ToeTac™
HOUSTON, Dec. 11, 2015 /PRNewswire/ -- Instratek, a privately held medical device company focused on minimally invasive endoscopic surgery and extremity implants, announces record revenue growth for the 10th straight year. The company recorded solid year over year revenue growth of its extremity endoscopy business and extremity implants, including the recently released nitinol fixation staple, STAPiX™.
"We released STAPiX about 6 months ago and are extremely pleased with the market response. Today we are announcing the release of our newest product ToeTac for the treatment of hammertoe deformities," said Jeff Seavey, President and CEO of Instratek. ToeTac is currently being launched and is anticipated to fuel the continued growth of the company for 2016. "Our foot print in the extremity market continues to expand and we will make every opportunity to innovate with new products focused in the extremity market."
The ToeTac implant is a one-piece, cannulated PEEK device that threads into the middle phalanx and pressfits into the proximal phalanx, providing a stable construct for PIP fusions. PEEK is a non-resorbable polymer that mimics the stiffness of bone and has high fatigue strength.
ToeTac kits are sterile, single-use, and fully disposable providing the most advanced hammertoe implant solution for surgeons and individual patient needs. Extremity surgeons demand proven performance and surgically efficient products. With the introduction of ToeTac, Instratek is the first company to provide a sterile solution that includes a cannulated PEEK implant and reamers together in one kit. The Cup & Cone style reamers create congruent concave-convex surfaces maximizing bony contact surface area.
This device is intended for orthopaedic and podiatric surgery. ToeTac is available in the U.S. through Instratek's distributor-based sales force and by contacting Instratek directly. Visit:
http://www.instratek.com/toetac.php
ToeTac is the latest addition to Instratek's innovative product solutions for foot & ankle and hand surgery. Other innovative products include STAPiX nitinol staples, Jones-FX fifth metatarsal screws, Mini Cannulated Titanium Headed & Headless screws, CMC Cable FIX™, Endotrac-Endoscopic Carpal Tunnel Release System, Endoscopic Trigger Finger Release, Endoscopic Plantar Fasciotomy, Endoscopic Gastrocnemius Release, Endoscopic Decompression of the Intermetatarsal Nerve, and the Sub-Talar Lok arthroereisis implant.
Instratek is a global medical device company, specializing in the development, manufacturing, and marketing of endoscopic instrumentation and surgical implants for the field of extremity surgery. For more information, visit www.instratek.com.
Contact: Marketing Department 1.800.892.8020
[email protected]
SOURCE Instratek
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article